12th Annual IBA World Life Sciences Conference

Subjects include:

- Clinical trials: current trends and perspectives at a global level
- Data exclusivity/Bolar - the EU Pharma Package and other jurisdictions
- Antitrust and intellectual property - divisionals, patent settlements, unlawful PTEs and PTAs
- Preventive health and longevity: legal perspectives shaping the future of healthcare
- Cross-border intellectual property litigation
- Integration of pharma and MedTech with hospitals, clinics and pharmacies
- Liability and accountability in open science research
- Combination products (drug-device) regulation: emerging legal complexities
- Preparing for the entry into force of the WIPO GRATK Treaty
- Artificial intelligence and biotechnology: rethinking patent standards
- AI and data rights in life sciences and HealthTech deals (training data, model outputs and infringement risk)
- Collaboration and licensing structures as financing tools
- Life sciences M and A in uncertain markets - earnouts, contingent value rights, contingent milestones and intellectual property-driven valuation mechanics
- Late-stage private financings and IPO alternatives (crossovers, structured preferred, PIPEs, ATMs, registered directs)
- Cross-border investment constraints affecting financings and exits (CFIUS risk, sensitive health/genomic data and closing conditions)

URLs:
Website: https://go.evvnt.com/3479886-2?pid=2874
Sponsor: https://go.evvnt.com/3479886-3?pid=2874

Prices:
IBA Member: EUR 1305.00,
Non-member: EUR 1520.00,
Young lawyers (under 30 years): EUR 1520.00,
Academics / judges (full-time): EUR 1520.00,
Public lawyers: EUR 1520.00,
Corporate Counsel: EUR 1520.00

Category: Conferences | Business and Economics | Legal